United StatesHouse Bill 2450HR 2450

Prescription Drug Transparency and Affordability Act

Health

87 pages

house
senate
president

Last progress March 27, 2025 (8 months ago)

Introduced on March 27, 2025 by Kristen McDonald Rivet

Sponsors (4)

House Votes

Pending Committee

March 27, 2025 (8 months ago)

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Senate Votes

Vote Data Not Available

This bill aims to make prescription drugs more transparent and affordable by tightening federal oversight of companies that manage prescription drug benefits for health plans. It updates federal laws so these companies are watched more closely and held to clearer rules, with a focus on transparency and affordability.

Who is affected: people whose health plans use these companies, the plans that hire them, and the companies that provide pharmacy benefit management services.
What changes: adds new federal oversight of “entities that provide pharmacy benefit management services,” including a dedicated section focused on that oversight.

Prescription Drug Transparency and Affordability Act

Sponsors (4)

House Votes

Senate Votes

Presidential Signature

AI Summary

Text Versions

Amendments